In the BioHarmony Drug Report Database

"Preview" Icon

Valproic acid

Depakene, Stavzor (valproic acid) is a small molecule pharmaceutical. Valproic acid was first approved as Depakene on 1982-01-01. It is used to treat absence epilepsy, alzheimer disease, bipolar disorder, complex partial epilepsy, and epilepsy amongst others in the USA. It is known to target histone deacetylase 1.

 

Trade Name

 

Depakene, Stavzor
 

Common Name

 

valproic acid
 

ChEMBL ID

 

CHEMBL109
 

Indication

 

absence epilepsy, alzheimer disease, bipolar disorder, complex partial epilepsy, epilepsy, mood disorders
 

Drug Class

 

Image (chem structure or protein)

Valproic acid structure rendering